BOSTON--(BUSINESS WIRE)--Nara Biosciences Inc., a biotechnology company developing therapies for muscle wasting diseases and diseases of aging, announced today that it has completed an agreement with Boston University to license the MyoMouse discovery platform, developed in the laboratory of Dr. Kenneth Walsh. The exclusive license includes all commercial rights to novel therapeutic factors discovered using the MyoMouse.
